comparemela.com
Home
Live Updates
Sobi® receives positive CHMP opinion recommending appro
Sobi® receives positive CHMP opinion recommending appro
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
/PRNewswire/ -- Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion...
Related Keywords
Russia ,
Japan ,
Taiwan ,
Stockholm ,
Sweden ,
United States ,
Australia ,
America ,
Lydia Abad Franch ,
Prnewswire Sobi ,
Linkedin ,
Committee For Medicinal Products Human Use ,
Sobi Investor Relations Team ,
European Commission ,
Nasdaq ,
European Medicines Agency ,
Euronext ,
Head Of Research ,
Medicinal Products ,
Human Use ,
Medical Affairs ,
Chief Medical Officer ,
Alfa Prophylaxis ,
Severe Haemophilia ,
Englj Med ,
Orphan Drug ,
North Africa ,
Middle Eastern ,
North America ,
Middle East ,
Sobi Media ,
Swedish Orphan Biovitrum Ab ,